Martine A. Rothblatt
Chairperson & CEO at United Therapeutics; Director at BETA Technologies. Based in Silver Spring, Maryland.
- Rank
- 572nd of 14,452
- Companies held
- 2
- Largest holding
- UTHR, 100.0% of total
- Latest SEC filing
- Nov 18, 2026
What the $374M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| United Therapeutics UTHR Common Stock | Through Trust | 324,443 | $559.10 | $181M | 48.5% | Form 4, Nov 18, 2026 |
| United Therapeutics UTHR Common Stock | Through Trust | 249,108 | $559.10 | $139M | 37.2% | Form 4, Nov 18, 2026 |
| United Therapeutics UTHR Common Stock | Through Trust | 45,596 | $559.10 | $25.5M | 6.8% | Form 4, Nov 18, 2026 |
| United Therapeutics UTHR Common Stock | Directly | 40,513 | $559.10 | $22.7M | 6.1% | Form 4, Nov 18, 2026 |
| United Therapeutics UTHR Common Stock | Through Trust | 8,902 | $559.10 | $5.0M | 1.3% | Form 4, Nov 18, 2026 |
| BETA Technologies BETA Class A common stock | Directly | 8,213 | $18.83 | $155K | 0.0% | Form 4, Jun 11, 2026 |
| United Therapeutics UTHR Common Stock | Through Spouse | 166 | $559.10 | $93K | 0.0% | Form 4, Nov 18, 2026 |
Share counts are the amounts Martine A. Rothblatt reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 18, 2026 | Sold | UTHR | 120 | $570.82 | $68K | View |
| Nov 18, 2026 | Sold | UTHR | 80 | $571.63 | $46K | View |
| Nov 18, 2026 | Sold | UTHR | 140 | $573.40 | $80K | View |
| Nov 18, 2026 | Sold | UTHR | 259 | $574.36 | $149K | View |
| Nov 18, 2026 | Sold | UTHR | 201 | $575.26 | $116K | View |
| Nov 18, 2026 | Sold | UTHR | 440 | $576.65 | $254K | View |
| Nov 18, 2026 | Sold | UTHR | 909 | $577.59 | $525K | View |
| Nov 18, 2026 | Sold | UTHR | 838 | $578.59 | $485K | View |
| Nov 18, 2026 | Sold | UTHR | 628 | $579.55 | $364K | View |
| Nov 18, 2026 | Sold | UTHR | 420 | $580.76 | $244K | View |
| Nov 18, 2026 | Sold | UTHR | 696 | $581.79 | $405K | View |
| Nov 18, 2026 | Sold | UTHR | 439 | $582.80 | $256K | View |
| Nov 18, 2026 | Sold | UTHR | 123 | $583.74 | $72K | View |
| Nov 18, 2026 | Sold | UTHR | 77 | $584.95 | $45K | View |
| Nov 18, 2026 | Sold | UTHR | 40 | $586.74 | $23K | View |
| Nov 17, 2026 | Sold | UTHR | 373 | $576.16 | $215K | View |
| Nov 17, 2026 | Sold | UTHR | 1,017 | $577.14 | $587K | View |
| Nov 17, 2026 | Sold | UTHR | 1,763 | $578.17 | $1.0M | View |
| Nov 17, 2026 | Sold | UTHR | 1,127 | $579.11 | $653K | View |
| Nov 17, 2026 | Sold | UTHR | 955 | $580.13 | $554K | View |
| Nov 17, 2026 | Sold | UTHR | 1,112 | $581.18 | $646K | View |
| Nov 17, 2026 | Sold | UTHR | 449 | $582.57 | $262K | View |
| Nov 17, 2026 | Sold | UTHR | 2,004 | $583.22 | $1.2M | View |
| Nov 17, 2026 | Sold | UTHR | 381 | $584.22 | $223K | View |
| Nov 17, 2026 | Sold | UTHR | 79 | $585.27 | $46K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 569 | Hamid R. Moghadam Director, Prologis. San Francisco, CA | $376M |
| 570 | Alexis Borisy Director, Revolution Medicines. Redwood City, CA | $375M |
| 571 | Roberta Bainum 10% owner, Choice Hotels International. Fulton, MD | $375M |
| 572 | Martine A. Rothblatt Chairperson & CEO, United Therapeutics. Silver Spring, MD | $374M |
| 573 | Daniel J. Roberts Co-Chief Executive Officer, IREN | $373M |
| 574 | William G. Roberts Co-Chief Executive Officer, IREN | $373M |
| 575 | Kenneth Hao Director, Broadcom. Palo Alto, CA | $371M |
Other United Therapeutics insiders
All UTHR insiders- Paul A. Mahon$25.3MEVP & GENERAL COUNSEL. #4340 overall
- Michael Benkowitz$15.6MPRESIDENT AND COO. #6235 overall
- Tommy G. Thompson$12.6MDirector. #3591 overall
- Richard Giltner$12.2MDirector. #7555 overall
- James Edgemond$10.6MCFO AND TREASURER. #8437 overall
- Ray Kurzweil$7.4MDirector. #10888 overall
Questions
How much stock does Martine A. Rothblatt own?
Martine A. Rothblatt holds $374,040,476 in listed stock based on SEC filings and current prices, mostly United Therapeutics (UTHR). That ranks 572nd on the Stock Rich List.
Is this Martine A. Rothblatt's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Martine A. Rothblatt last buy or sell stock?
The most recent open-market trade on file is a sale of 120 UTHR shares on Nov 18, 2026 at $570.82.